CI

At a glance

ClinicalIndex Comparison Record
Phase 4Completed· 27 enrolled
Drug / intervention
VIVITROL 380mgdrug
Likely dose
VIVITROL 380mgfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT01453374
NCT01453374Phase 4Completed
CompareCT.gov

A Phase 4, Pilot, Open-label Study of VIVITROL in the Prevention of Re-arrest and Re-incarceration

Alkermes, Inc.·interventional·Posted Oct 17, 2011·Updated Jul 13, 2015

In Brief

A Phase 4 clinical trial evaluating VIVITROL 380mg for Opioid Dependence. Completed, enrolled 27 participants across 1 site.

Detailed Summary

This phase 4 study will evaluate the feasibility of initiating subjects on VIVITROL in prison and continuing VIVITROL upon release into the community.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsOpioid Dependence
CountriesUnited States
Collaborators--

Timeline

Phase 4CompletedFinished
2011201220132014201520162017201820192020202120222023202420252026
First PostedOct 17, 2011
Enrollment StartJan 1, 2011
Primary CompletionMay 1, 2014
TodayJul 2, 2026
Enrollment to primary: 3.3 yearsPosted 14.7 years ago

Interventions

VIVITROL 380mgdrug

380 mg IM injection given once monthly